| Jessica Ann Reviea, FNP-C | |
|
1594 Freedom Blvd Ste 100, Florence, SC 29505-6046 | |
| (843) 674-4787 | |
| Not Available |
| Full Name | Jessica Ann Reviea |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 2 Years |
| Location | 1594 Freedom Blvd Ste 100, Florence, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003564691 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 27371 (South Carolina) | Primary |
| 363LF0000X | Nurse Practitioner - Family | APRN.CNP.0030983 (Ohio) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Musc Health Florence Medical Center | Florence, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Musc Community Physicians | 6507260668 | 698 |
News Archive
Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc., announced the successful filing of an Investigational New Drug Application for IPX159 in Restless Legs Syndrome and initiated a Phase I study.
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved Mekinist® (trametinib) for use in combination with Tafinlar® (dabrafenib) for the treatment of patients with unresectable melanoma (melanoma that cannot be removed by surgery) or metastatic melanoma (melanoma which has spread to other parts of the body) with BRAF V600E or V600K mutations.
Quite a lot - according to teachers in a recent survey commissioned by The Innovation Unit and carried out by researchers at the University of Bristol.
Kaiser Health News staff writer Jenny Gold, working in collaboration with NPR, reports on a new way for patients to find physicians: "It's Tuesday afternoon, and time for speed dating to begin - at a local hospital near Dallas.
› Verified 5 days ago
| Entity Name | Musc Community Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841878006 PECOS PAC ID: 6507260668 Enrollment ID: O20210811002388 |
News Archive
Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc., announced the successful filing of an Investigational New Drug Application for IPX159 in Restless Legs Syndrome and initiated a Phase I study.
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved Mekinist® (trametinib) for use in combination with Tafinlar® (dabrafenib) for the treatment of patients with unresectable melanoma (melanoma that cannot be removed by surgery) or metastatic melanoma (melanoma which has spread to other parts of the body) with BRAF V600E or V600K mutations.
Quite a lot - according to teachers in a recent survey commissioned by The Innovation Unit and carried out by researchers at the University of Bristol.
Kaiser Health News staff writer Jenny Gold, working in collaboration with NPR, reports on a new way for patients to find physicians: "It's Tuesday afternoon, and time for speed dating to begin - at a local hospital near Dallas.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Ann Reviea, FNP-C Po Box 23321, New York, NY 10087-4321 Ph: () - | Jessica Ann Reviea, FNP-C 1594 Freedom Blvd Ste 100, Florence, SC 29505-6046 Ph: (843) 674-4787 |
News Archive
Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc., announced the successful filing of an Investigational New Drug Application for IPX159 in Restless Legs Syndrome and initiated a Phase I study.
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved Mekinist® (trametinib) for use in combination with Tafinlar® (dabrafenib) for the treatment of patients with unresectable melanoma (melanoma that cannot be removed by surgery) or metastatic melanoma (melanoma which has spread to other parts of the body) with BRAF V600E or V600K mutations.
Quite a lot - according to teachers in a recent survey commissioned by The Innovation Unit and carried out by researchers at the University of Bristol.
Kaiser Health News staff writer Jenny Gold, working in collaboration with NPR, reports on a new way for patients to find physicians: "It's Tuesday afternoon, and time for speed dating to begin - at a local hospital near Dallas.
› Verified 5 days ago
Mrs. Callie Hanson Carpenter, F.N.P Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 555 E Cheves St, Florence, SC 29506 Phone: 843-777-2000 | |
Jennifer Lucas Reid, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 214 W Pine St, Florence, SC 29501 Phone: 843-661-0500 Fax: 436-617-3708 | |
Christy Mcwhite, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 145 E Cheves St, Florence, SC 29506 Phone: 843-661-4835 | |
Betty Gattison, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1100 E Cheves St, Florence, SC 29506 Phone: 843-669-6694 | |
Theressa L Garris, PNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 204 E Cheves St, Florence, SC 29506 Phone: 843-777-7601 Fax: 843-662-2474 | |
Michelle D Poston, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 360 N Irby St, Florence, SC 29501 Phone: 843-667-9414 Fax: 843-667-1362 |